Cancer of the uterine cervix may be significantly associated with a gene polymorphism coding for increased IL-10 production

International Journal of Cancer

Volumn 94, Issue 6, 2001, Pages 792-794

  Stanczuk, Grazyna A ^a   Sibanda, Elopy N ^a,c   Perrey, Chris ^b   Chirara, Mike ^b   Pravica, Vera ^a   Hutchinson, Ian V ^a   Tswana, Sam A ^a  

^a UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIV OF ZIMBABWE MEDICAL SCHOOL   (Zimbabwe)

Author keywords

Cervical cancer; IL 10 cytokine gene polymorphisms; Zimbabwe

Indexed keywords

INTERLEUKIN 10;

ADULT; AGE; AGED; ARTICLE; CASE CONTROL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA POLYMORPHISM; ETHNIC GROUP; FEMALE; GEL ELECTROPHORESIS; GENETIC PREDISPOSITION; HUMAN; MAJOR CLINICAL STUDY; PARITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; ZIMBABWE;

ADULT; AGED; FEMALE; HUMANS; INTERLEUKIN-10; MIDDLE AGED; POLYMORPHISM, GENETIC; UTERINE CERVICAL NEOPLASMS;

EID: 0035892319     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1543     Document Type: Article

References (39)

1. Prevalence of human papillomavirus in cervical cancer a worldwide perspective
2. Concordance of human papillomavirus in the cervix and urine among inner city adolescents
3. HPV-based cervical cancer screening in a population at high risk for HIV infection
4. Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, East Africa
5. High risk human papillomavirus in women with normal cervical cytology prior to the development of abnormal cytology and colposcopy
6. Relationship between human papillomavirus type 16 in the cervix and epithelial neoplasia
7. Immunology of papillomavirus infection
8. Lymphoproliferative responses to human papillomavirus (HPV) type 16 proteins E6 and E7: Outcome of HPV infection and associated neoplasia
9. Interleukin-10
10. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes
11. B7-1 expression of Langerhans cells is upregulated by pro-inflammatory cytokines, and is down-regulated by interferon gamma or by interleukin-10
12. Production of interleukin-10 by human bronchogenic carcinoma
13. Human non-small cell lung cancer cells express a type 2 cytokine pattern
14. Host immune response in renal cell cancer: Interleukin-4 (IL-4) and IL-10 mRNA are frequently detected in freshly collected tumor-infiltrating lymphocytes
15. Selective cytokine gene expression in renal cell carcinoma tumor cell and tumor-infiltrating lymphocytes
16. Lack of interleukin-2 (IL-2) expression and selective expression of IL-10 mRNA in human renal cell carcinoma
17. Messenger RNA expression of the immunosuppressive cytokine IL-10 in human gliomas
18. Production of IL-10 by melanoma cells: Examination of its role in immunosuppression mediated by melanoma
19. Cytokine production patterns in cervical intraepithelial neoplasia: Association with Human Papillomavirus infection
20. Cytokine expression in squamous intraepithelial lesions of the uterine cervix: Implications for the generation of local immunosuppression
21. Differences in cytokine mRNA profiles between premalignant and malignant lesions of the uterine cervix
22. Circulating serum levels of cytokines and angiogenic factors in patients with cervical cancer
23. IL-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T cell immune response
24. Expression of interleukin 10 in human melanoma
25. Genetic link to cervical tumours
26. Differences in cervical cancer mortality among black and white women
27. Identification of high and low responders to allografts
28. An investigation of polymorphism in the interleukin-10 gene promoter
29. Interleukin 10 secretion in relation to human IL-10 locus haplotypes
30. ARMS-PCR methodologies to determine IL-10, TNF-alpha and TGF-beta-1 gene polymorphisms
31. IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells
32. Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression
33. Fas ligand mediated exocrinopathy resembling Sjogren's syndrome in mice transgenic for IL-10
34. Interleukin 10 promotes activation induced cell death of SLE lymphocytes mediated by FAS ligand
35. Simultaneous exposure to interleukin-18 and interleukin 10 in vitro synergistically augments murine spleen natural killer cell activity
36. IL-10 induces apoptosis in human monocytes involving the CD95 receptor/ligand pathway
37. Inhibition of Langerhans cell antigen-presenting function by IL-10: A role for IL-10 in induction of tolerance
38. Induction of tolerance by IL-10-treated dendritic cells
39. Cytokine dysregulation in invasive cervical carcinoma and other human neoplasias: Time to consider the TH1/TH2 paradigm